In our study, we performed a bioinformatic analysis and combined it with an assessment of the concentrations of synaptic dysfunction biomarkers (Ng, NPTXR), as well as one for neuronal injury (VILIP1), to verify the association between the analysis of molecular functions and dynamics of the concentration changes in dementia stages. This evidence concerns the gene NRGN and dementia.